203 related articles for article (PubMed ID: 24611770)
1. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
[TBL] [Abstract][Full Text] [Related]
2. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.
Chang KC; Liang JT; Tsai PS; Wu MS; Hsu KL
Br J Pharmacol; 2009 Aug; 157(8):1419-26. PubMed ID: 19681870
[TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of glycation and AGE formation.
Rahbar S
Cell Biochem Biophys; 2007; 48(2-3):147-57. PubMed ID: 17709884
[TBL] [Abstract][Full Text] [Related]
4. Arterial stiffening and cardiac hypertrophy in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Chou TF; Cho YL; Chi TC; Su MJ; Tseng YZ
Eur J Clin Invest; 2006 Jan; 36(1):1-7. PubMed ID: 16403003
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
6. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.
Chang KC; Hsu KL; Tseng CD; Lin YD; Cho YL; Tseng YZ
Br J Pharmacol; 2006 Apr; 147(8):944-50. PubMed ID: 16491102
[TBL] [Abstract][Full Text] [Related]
7. Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.
Wu ET; Liang JT; Wu MS; Chang KC
Exp Gerontol; 2011 Jun; 46(6):482-8. PubMed ID: 21316441
[TBL] [Abstract][Full Text] [Related]
8. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.
Figarola JL; Scott S; Loera S; Tessler C; Chu P; Weiss L; Hardy J; Rahbar S
Diabetologia; 2003 Aug; 46(8):1140-52. PubMed ID: 12845431
[TBL] [Abstract][Full Text] [Related]
9. Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats.
Babu PV; Sabitha KE; Srinivasan P; Shyamaladevi CS
Pharmacol Res; 2007 May; 55(5):433-40. PubMed ID: 17336542
[TBL] [Abstract][Full Text] [Related]
10. Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.
Chang KC; Hsu KL; Peng YI; Lee FC; Tseng YZ
Br J Pharmacol; 2003 Sep; 140(1):107-14. PubMed ID: 12967940
[TBL] [Abstract][Full Text] [Related]
11. Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde.
Wang CH; Chang RW; Ko YH; Tsai PR; Wang SS; Chen YS; Ko WJ; Chang CY; Young TH; Chang KC
PLoS One; 2014; 9(3):e90471. PubMed ID: 24595201
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
13. Aminoguanidine prevents fructose-induced arterial stiffening in Wistar rats: aortic impedance analysis.
Lin YT; Tseng YZ; Chang KC
Exp Biol Med (Maywood); 2004 Nov; 229(10):1038-45. PubMed ID: 15522840
[TBL] [Abstract][Full Text] [Related]
14. Effects of diabetes and gender on mechanical properties of the arterial system in rats: aortic impedance analysis.
Chang KC; Hsu KL; Tseng YZ
Exp Biol Med (Maywood); 2003 Jan; 228(1):70-8. PubMed ID: 12524476
[TBL] [Abstract][Full Text] [Related]
15. Skin Autofluorescence and Pentosidine Are Associated With Aortic Stiffening: The Maastricht Study.
van Eupen MG; Schram MT; van Sloten TT; Scheijen J; Sep SJ; van der Kallen CJ; Dagnelie PC; Koster A; Schaper N; Henry RM; Kroon AA; Smit AJ; Stehouwer CD; Schalkwijk CG
Hypertension; 2016 Oct; 68(4):956-63. PubMed ID: 27550921
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury.
Soulis T; Thallas V; Youssef S; Gilbert RE; McWilliam BG; Murray-McIntosh RP; Cooper ME
Diabetologia; 1997 Jun; 40(6):619-28. PubMed ID: 9222639
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats.
Cheng G; Wang LL; Long L; Liu HY; Cui H; Qu WS; Li S
Br J Pharmacol; 2007 Dec; 152(8):1196-206. PubMed ID: 17965740
[TBL] [Abstract][Full Text] [Related]
18. Effects of olmesartan on arterial stiffness in rats with chronic renal failure.
Chuang YC; Wu MS; Su YK; Fang KM
Cardiovasc Diabetol; 2012 Jun; 11():66. PubMed ID: 22694778
[TBL] [Abstract][Full Text] [Related]
19. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
Bhatwadekar A; Glenn JV; Figarola JL; Scott S; Gardiner TA; Rahbar S; Stitt AW
Br J Ophthalmol; 2008 Apr; 92(4):545-7. PubMed ID: 18211931
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling.
Jing YH; Chen KH; Yang SH; Kuo PC; Chen JK
Diabetes Metab Res Rev; 2010 Mar; 26(3):212-22. PubMed ID: 20474069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
